Skip Content
 
Page Banner Image

2017 HSC National Symposium

Saturday, October 14th, 2017

2017 Huntington Society of Canada National Symposium.

The National Symposium is an opportunity to gather with the local HD community in your area and learn about the latest in Huntington disease research.

The National Symposium is hosted by volunteers at multiple sites across Canada every two years. Presentations are then live-streamed across Canada, allowing those at Symposium locations to ask questions of presenters in real time. These locations often offer additional programming to facilitate networking with other HD families, healthcare professionals and local HSC staff. Presentations are also available to view from the comfort of your own home for those unable to travel to a Symposium location.

Presentation One: The Silver Lining: Learning from Unsuccessful HD Clinical Trials

                

Click here for a summary of Dr. Maiuri’s presentation. 

Join researcher, Dr. Tamara Maiuri from McMaster University, to learn about the results of recent HD Clinical trials including Amaryllis, OpenHeart, Premordien and Pride. Together we will understand why these trials were stopped, but more importantly, what researchers learned that will continue to guide us in the future for treatments of Huntington disease.

Presentation Two: What’s Next? Clinical Trials in HD throughout Canada

Our panel of researchers, including Dr. Mark Guttman from Centre for Movement Disorders, Toronto, Dr. Blair Leavitt from the University of British Columbia, and Dr. Oksana Suchowersky of the University of Alberta will each share the latest news on their research and upcoming clinical trials, including HD-Clarity, Huntingtin Lowering, and GM-1. Moderated by HSC CEO Bev Heim-Myers, this presentation is sure to lead you to Believe!

Click here for a summary of Dr. Guttman, Dr. Leavitt and Dr. Suchowersky’s presentation.

Dr. Mark Guttman Q & A:

What is the process for patients who are seen at different clinics (eg North York General) but would like to be a part of the Precision-HD trial?

Discussions are in place to determine a process. I would like to see potential patients clinically to get to know them before offering participation in the study, otherwise they need to be referred by their doctor with supporting documents sent to my office.

Has anyone been enrolled for the WAVE trial yet?

The first patient has not yet been dosed. Hopefully within a few weeks the first dose will be received.

Symposium Locations:

Vancouver, British Columbia

Victoria, British Columbia

Kelowna, British Columbia

Edmonton, Alberta

Calgary, Alberta

Saskatoon, Saskatchewan

Winnipeg, Manitoba

Thunder Bay, Ontario – October 18, 2017

London, Ontario

Guelph, Ontario

Toronto, Ontario

Barrie, Ontario

Peterborough, Ontario

Kingston, Ontario

Ottawa, Ontario

Halifax, Nova Scotia

Quispamsis, New Brunswick

St. John’s, Newfoundland

 


We support those facing huntington disease
 Latest Blog
 Questions

Questions

Let Us Know How We Can Help
Enter your name, email address and question(s) below for assistance.

Questions

 Connect
 Newsletter

Newsletter

Stay in Touch!
Enter your email address below to receive occasional updates.

Newsletter Sign-up